Home Levels of C-Telopeptide Fragments of Collagen Type I Enable the Monitoring and Early Adjustment of Clodronate Therapy in Patients with Postmenopausal Osteoporosis
Article
Licensed
Unlicensed Requires Authentication

Levels of C-Telopeptide Fragments of Collagen Type I Enable the Monitoring and Early Adjustment of Clodronate Therapy in Patients with Postmenopausal Osteoporosis

  • Alessio Borean , Marina De Prà , Giorgio Farina , Paolo Nalin and Paolo Rizzotti
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 38 Issue 6

Abstract

We monitored the efficacy of therapy with clodronate, a bisphosphonate drug, in women with postmenopausal osteoporosis, using urinary immunoenzymatic assay of C-telopeptide of collagen type I, an eight amino acid fragment (collagen fragment) of the C-telopeptide of the α1-chain of collagen type I (EKAHDGGR). The analysis of the dynamics of collagen fragment concentrations (a marker of bone resorption) during treatment suggests the possibility of early modulation and customization of therapy based on the levels of this marker. This could enable improved control over secondary effects and side effects of clodronate therapy. Pharmacologic inhibition of bone resorption by osteoclasts could be indirectly responsible for the increase in parathyroid hormone found during treatment with clodronate. Increased levels of parathyroid hormone are probably necessary to stimulate residual osteoclast activity and are sufficient for the maintenance of calcium-phosphate homeostasis in a new pharmacologically-induced equilibrium. Outside this context the levels of parathyroid hormone of certain patients would be considered pathologic.

:
Published Online: 2005-06-01
Published in Print: 2000-06-11

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Integrons: an Antibiotic Resistance Gene Capture and Expression System
  2. Levels of C-Telopeptide Fragments of Collagen Type I Enable the Monitoring and Early Adjustment of Clodronate Therapy in Patients with Postmenopausal Osteoporosis
  3. Probable Involvement of Cathepsin D in the Degradation of β2-Microglobulin in Acidic Urine
  4. Autoantibodies against Oxidized Low-Density Lipoprotein Correlate with Achilles Tendon Xanthomas
  5. Regulation of the Hepatic Endothelin System in Advanced Biliary Fibrosis in Rats
  6. Determination of Plasma Methoxyamines
  7. Stability of Brain Natriuretic Peptide (BNP) in Human Whole Blood and Plasma
  8. Effect of Short- and Long-Term Storage on Human Serum and Recombinant Apolipoprotein E Concentration
  9. Comparison of Laboratory Parameters as Risk Factors for the Presence and the Extent of Coronary or Carotid Atherosclerosis: the Significance of Apolipoprotein B to Apolipoprotein AII Ratio
  10. The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population
  11. A Model for Setting Analytical Quality Specifications and Design of Control for Measurements on the Ordinal Scale
  12. Transformation in the PC-Aided Biochemical Data Analysis
  13. Concordance of Eight Kits for Antithyroid Peroxidase Autoantibodies Determination
  14. Evaluation of a Point-of-Care System for Quantitative Determination of Troponin T and Myoglobin
  15. The Maillard Reaction in Foods and Medicine. By John OBrien, Harry E. Nursden, M. James, C. Crabbe and Jennifer M. Ames, editors
  16. Apoptosis and Inflammation. By J.D. Winkler, editor
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.071/html
Scroll to top button